查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲类器官市场预测至 2030 年 - 区域分析 - 按器官类型、应用、来源和类型
市场调查报告书
商品编码
1402761

欧洲类器官市场预测至 2030 年 - 区域分析 - 按器官类型、应用、来源和类型

Europe Organoids Market Forecast to 2030 - Regional Analysis - by Organ Type, Application, Source, and Type
出版日期: | 出版商: The Insight Partners | 英文 99 Pages | 订单完成后即时交付

价格

欧洲类器官市场预计将从2022年的8.4219亿美元成长到2030年的40.8052亿美元。预计2022年至2030年CAGR为21.8%。

欧洲类器官市场越来越多地采用个人化药物

个人化医疗，也称为精准医疗，是一种根据预期的反应或疾病风险为个别患者量身定製程序或药物的医疗模式。根据个人化医疗联盟(PMC) 发表的一项研究，2005 年个人化药物仅占FDA 批准的新分子实体的5%，而2016 年则占了25% 以上。此外，占所有化合物和药物的42 % 73% 的研发中肿瘤化合物有潜力成为个人化药物。此外，生物製药公司在过去五年中对个人化药物的研发投入几乎翻了一番，未来五年可能会增加33%。生物製药研究人员也预测，未来五年个人化药物的开发将成长 69%。

使用类器官来创建个人化药物疗法为改善患者护理提供了令人兴奋的机会。此外，药剂师在增加个人化药物需求方面发挥着重要作用，因为他们积极宣传精准医疗并提高人们的意识。最近的研究表明，超过 50% 的消费者有兴趣购买客製化产品或服务。这种需求促使药物研究发展出更有针对性的治疗方法，使药物更安全、更有效。

个人化癌症医学是一种根据肿瘤基因组特征为每位患者制定有效治疗策略的方法。对个人化肿瘤模型研究的需求不断增加，以确认临床前环境中基因组药物反应预测的功能。许多研究强调了肿瘤类器官在个人化癌症医学中在基因药物关联治疗、新疗法鑑定和患者预后预测方面的应用。

个人化癌症治疗对每位患者进行特定的治疗。使用与原始肿瘤具有相似特征的个人化肿瘤模型可能会准确预测患者的药物反应。肿瘤类器官模型有几个优点，例如与预先存在的模型相比，保留了原始肿瘤的分子和细胞组成。这些优点凸显了肿瘤类器官在个人化癌症治疗中的巨大潜力，特别是在临床前药物筛选和预测患者对选定治疗方案的反应。

欧洲类器官市场概况

欧洲类器官市场细分为德国、法国、义大利、英国、西班牙和欧洲其他地区。区域市场的成长与组织工程和器官移植的需求不断增长有关；越来越多地采用类器官进行疾病建模、基因突变和肿瘤建模；以及不断增长的类器官研究活动。此外，资金增加和公私投资等因素可能会在未来几年为该地区带来更多机会。

欧洲类器官市场收入及 2030 年预测（百万美元）

欧洲类器官市场细分

欧洲类器官市场分为器官类型、类型、应用、来源和国家。

依器官类型，欧洲类器官市场分为肠、肝、胃、胰臟、肺、脑、肾等。 2022 年，肠道领域在欧洲类器官市场中占最大份额。

根据类型，欧洲类器官市场分为仪器、消耗品和服务。 2022 年，消耗品领域在欧洲类器官市场中占最大份额。

根据应用，欧洲类器官市场分为发育生物学疾病、传染病病理学、再生医学、药物毒性和功效测试、药物发现和个人化医疗等。到 2022 年，发育生物学疾病领域将占据欧洲类器官市场的最大份额。

根据来源，欧洲类器官市场分为多能干细胞和器官特异性成体干细胞。到 2022 年，多能干细胞细分市场将在欧洲类器官市场中占据更大份额。

根据国家/地区，欧洲类器官市场分为德国、法国、英国、义大利、西班牙和欧洲其他地区。 2022 年，德国在欧洲类器官市场占据主导地位。

Cellesce、Definigen、Hubrecht Organoid Technology、InSphero、Merck KGaA、STEMCELL Technologies Inc 和 Thermo Fisher Scientific Inc 是欧洲类器官市场上的一些领先公司。

目录

第 1 章：简介

  • Insight Partners 研究报告指南
  • 市场区隔

第 2 章：执行摘要

  • 欧洲关键见解
  • 欧洲市场吸引力

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：欧洲类器官市场格局

  • 概述
  • 欧洲PEST分析

第 5 章：欧洲类器官市场 - 主要产业动态

  • 主要市场驱动因素：
    • 对肿瘤建模和生物样本库的需求不断增加
    • 越来越多地采用个人化药物
    • 人们日益关注开发动物测试模型的替代方案
  • 主要市场限制：
    • 与将类器官纳入现有工作流程相关的问题
    • 缺乏熟练的专业人员
  • 主要市场机会：
    • 专注于药物发现活动
  • 未来的趋势：
    • 将类器官与器官晶片结合
  • 影响分析：

第 6 章：类器官市场 - 欧洲市场分析

  • 欧洲类器官市场收入，2022 - 2030

第 7 章：欧洲类器官市场 - 2030 年收入与预测 - 按器官类型

  • 概述
  • 2022 年及 2030 年欧洲类器官市场收入份额，依器官类型划分 (%)
  • 胃
  • 肠
  • 肝
  • 胰臟
  • 肺
  • 脑
  • 肾
  • 其他的

第 8 章：欧洲类器官市场 - 收入和 2030 年预测 -按应用

  • 概述
  • 2022 年及 2030 年欧洲类器官市场收入份额，依应用划分 (%)
  • 发育生物学
  • 传染病的疾病病理学
  • 再生医学
  • 药物毒性和药效测试
  • 药物发现与个人化医疗
  • 其他的

第 9 章：欧洲类器官市场 - 收入和 2030 年预测 - 按来源

  • 概述
  • 2022 年及 2030 年欧洲类器官市场收入份额（按来源划分）（%）
  • 多能干细胞
  • 器官特异性成体干细胞

第 10 章：欧洲类器官市场 - 收入和 2030 年预测 - 按类型

  • 概述
  • 欧洲类器官市场收入份额，按类型 2022 年和 2030 年 (%)
  • 仪器
  • 耗材
  • 服务

第 11 章：欧洲类器官市场 - 国家分析

    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区

第 12 章：COVID-19 前后的影响

  • COVID-19 前后的影响

第 13 章：欧洲类器官市场产业格局

  • 概述
  • 市场上公司采取的成长策略，(%)
  • 有机发展
    • 概述
  • 无机发展
    • 概述

第 14 章：欧洲类器官市场，主要公司概况

  • STEMCELL Technologies Inc.
  • Cellesce Ltd
  • Hubrecht Organoid Technology
  • Definigen
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • InSphero

第 15 章：附录

  • 关于我们
  • 专业术语
Product Code: TIPRE00018856

The Europe organoids market is expected to grow from US$ 842.19 million in 2022 to US$ 4,080.52 million by 2030. It is estimated to grow at a CAGR of 21.8% from 2022 to 2030.

Growing Adoption of Personalized Drugs in Europe Organoids Market

Personalized medicine, also known as precision medicine, is a medical model that practices procedures or drugs tailored to the individual patient based on the projected response or risk of disease. According to a study published by Personalized Medicine Coalition (PMC), personalized medicines accounted for only 5% of the new FDA-approved molecular entities in 2005, whereas they accounted for more than 25% in 2016. Additionally, 42% of all compounds and 73% of oncology compounds in the pipeline have the potential to be personalized medicines. Moreover, biopharmaceutical companies nearly doubled their R&D investment in personalized drugs over the past five years, which is likely to increase by 33% in the next five years. Biopharmaceutical researchers also predict a 69% increase in the development of personalized medicines over the coming five years.

The implementation of organoids to create personalized drug therapies provides exciting opportunities for improving patient care. In addition, pharmacists play an essential role in increasing the demand for personalized medicines as they proactively educate and create awareness about precision medicine. Recent research has highlighted that more than 50% of consumers are interested in purchasing customized products or services. This demand has persuaded pharmaceutical research to develop more tailored treatments to make medicines safer and more effective.

Personalized cancer medicine is an approach to tailoring effective therapeutic strategies for each patient according to a tumor's genomic characterization. There is an increasing demand for research in personalized tumor modeling to confirm the functional aspects of genomic drug response predictions in the preclinical setting. Numerous studies have highlighted the application of tumor organoids in personalized cancer medicine in terms of gene-drug association treatment, identification of new therapies, and prediction of patient outcomes.

Personalized cancer therapy applies specific treatments to each patient. Using personalized tumor models with similar characteristics to the original tumors may result in accurate predictions of drug responses in patients. Tumor organoid models have several advantages, such as conserving the molecular and cellular composition of the original tumor over pre-existing models. These advantages highlight the tremendous potential of tumor organoids in personalized cancer therapy, particularly in preclinical drug screening and predicting patient responses to selected treatment regimens.

Europe Organoids Market Overview

The Europe organoids market is sub-segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. The regional market growth is associated with the rising demand for tissue engineering and organ transplantation; increasing adoption of organoids for disease modeling, gene mutation, and tumor modeling; and growing research activities on organoids. In addition, factors such as increased funding and public-private investments will likely add more opportunities in the coming years in the region.

Europe Organoids Market Revenue and Forecast to 2030 (US$ Million)

Europe Organoids Market Segmentation

The Europe organoids market is segmented into organ type, type, application, source, and country.

Based on organ type, the Europe organoids market is segmented into intestine, liver, stomach, pancreas, lung, brain, kidney, and others. The intestine segment held the largest share of the Europe organoids market in 2022.

Based on type, the Europe organoids market is segmented into instruments, consumables, and services. The consumables segment held the largest share of the Europe organoids market in 2022.

Based on application, the Europe organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held largest share of the Europe organoids market in 2022.

Based on source, the Europe organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cell. The pluripotent stem cells segment held a larger share of the Europe organoids market in 2022.

Based on country, the Europe organoids market is segmented into the Germany, France, the United Kingdom, Italy, Spain, and the Rest of Europe. Germany dominated the Europe organoids market in 2022.

Cellesce, Definigen, Hubrecht Organoid Technology, InSphero, Merck KGaA, STEMCELL Technologies Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Europe organoids market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe organoids market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Europe organoids market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Europe Key Insights
  • 2.2 Europe Market Attractiveness

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Organoids Market Landscape

  • 4.1 Overview
  • 4.2 Europe PEST Analysis

5. Europe Organoids Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Increasing Demand for Tumor Modeling and Biobanking
    • 5.1.2 Growing Adoption of Personalized Drugs
    • 5.1.3 Rising Focus on Developing Alternatives for Animal Testing Models
  • 5.2 Key Market Restraints:
    • 5.2.1 Issues Related to Incorporation of Organoids into Existing Workflows
    • 5.2.2 Dearth of Skilled Professionals
  • 5.3 Key Market Opportunities:
    • 5.3.1 Focus on Drug Discovery Activities
  • 5.4 Future Trends:
    • 5.4.1 Combining Organoid with Organ-On-A-Chip
  • 5.5 Impact Analysis:

6. Organoids Market - Europe Market Analysis

  • 6.1 Europe Organoids Market Revenue (US$ Mn), 2022 - 2030

7. Europe Organoids Market - Revenue and Forecast to 2030 - by Organ Type

  • 7.1 Overview
  • 7.2 Europe Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
  • 7.3 Stomach
    • 7.3.1 Overview
    • 7.3.2 Stomach: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Intestine
    • 7.4.1 Overview
    • 7.4.2 Intestine: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Liver
    • 7.5.1 Overview
    • 7.5.2 Liver: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Pancreas
    • 7.6.1 Overview
    • 7.6.2 Pancreas: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Lung
    • 7.7.1 Overview
    • 7.7.2 Lung: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Brain
    • 7.8.1 Overview
    • 7.8.2 Brain: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.9 Kidney
    • 7.9.1 Overview
    • 7.9.2 Kidney: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.10 Others
    • 7.10.1 Overview
    • 7.10.2 Others: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Organoids Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Europe Organoids Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Developmental Biology
    • 8.3.1 Overview
    • 8.3.2 Developmental Biology: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Disease Pathology of Infectious Disease
    • 8.4.1 Overview
    • 8.4.2 Disease Pathology of Infectious Disease: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Regenerative Medicine
    • 8.5.1 Overview
    • 8.5.2 Regenerative Medicine: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Drug Toxicity and Efficacy Testing
    • 8.6.1 Overview
    • 8.6.2 Drug Toxicity and Efficacy Testing: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Drug Discovery and Personalized Medicine
    • 8.7.1 Overview
    • 8.7.2 Drug Discovery and Personalized Medicine: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Organoids Market - Revenue and Forecast to 2030 - by Source

  • 9.1 Overview
  • 9.2 Europe Organoids Market Revenue Share, by Source 2022 & 2030 (%)
  • 9.3 Pluripotent Stem Cells
    • 9.3.1 Overview
    • 9.3.2 Pluripotent Stem Cells: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Organ-specific Adult Stem Cells
    • 9.4.1 Overview
    • 9.4.2 Organ-specific Adult Stem Cells: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Organoids Market - Revenue and Forecast to 2030 - by Type

  • 10.1 Overview
  • 10.2 Europe Organoids Market Revenue Share, by Type 2022 & 2030 (%)
  • 10.3 Instruments
    • 10.3.1 Overview
    • 10.3.2 Instruments: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Consumables
    • 10.4.1 Overview
    • 10.4.2 Consumables: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Services
    • 10.5.1 Overview
    • 10.5.2 Services: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Organoids Market - Country Analysis

  • 11.1 Europe Organoids Market: Overview
    • 11.1.1 Europe Organoids Market by Country
      • 11.1.1.1 Germany
        • 11.1.1.1.1 Overview
        • 11.1.1.1.2 Germany Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.1.3 Germany Organoids Market, by Organ Type
        • 11.1.1.1.4 Germany Organoids Market, by Application
        • 11.1.1.1.5 Germany Organoids Market, by Source
        • 11.1.1.1.6 Germany Organoids Market, by Type
      • 11.1.1.2 UK
        • 11.1.1.2.1 Overview
        • 11.1.1.2.2 UK Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.2.3 UK Organoids Market, by Organ Type
        • 11.1.1.2.4 UK Organoids Market, by Application
        • 11.1.1.2.5 UK Organoids Market, by Source
        • 11.1.1.2.6 UK Organoids Market, by Type
      • 11.1.1.3 France
        • 11.1.1.3.1 Overview
        • 11.1.1.3.2 France Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.3.3 France Organoids Market, by Organ Type
        • 11.1.1.3.4 France Organoids Market, by Application
        • 11.1.1.3.5 France Organoids Market, by Source
        • 11.1.1.3.6 UK Organoids Market, by Type
      • 11.1.1.4 Italy
        • 11.1.1.4.1 Overview
        • 11.1.1.4.2 Italy Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.4.3 Italy Organoids Market, by Organ Type
        • 11.1.1.4.4 Italy Organoids Market, by Application
        • 11.1.1.4.5 Italy Organoids Market, by Source
        • 11.1.1.4.6 Italy Organoids Market, by Type
      • 11.1.1.5 Spain
        • 11.1.1.5.1 Overview
        • 11.1.1.5.2 Spain Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.5.3 Spain Organoids Market, by Organ Type
        • 11.1.1.5.4 Spain Organoids Market, by Application
        • 11.1.1.5.5 Spain Organoids Market, by Source
        • 11.1.1.5.6 Spain Organoids Market, by Type
      • 11.1.1.6 Rest of Europe
        • 11.1.1.6.1 Overview
        • 11.1.1.6.2 Rest of Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.6.3 Rest of Europe Organoids Market, by Organ Type
        • 11.1.1.6.4 Rest of Europe Organoids Market, by Application
        • 11.1.1.6.5 Rest of Europe Organoids Market, by Source
        • 11.1.1.6.6 Rest of Europe Organoids Market, by Type

12. Pre & Post COVID-19 Impact

  • 12.1 Pre & Post COVID-19 Impact

13. Europe Organoids Market Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies Done by the Companies in the Market, (%)
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.4 Inorganic Developments
    • 13.4.1 Overview

14. Europe Organoids Market, Key Company Profiles

  • 14.1 STEMCELL Technologies Inc.
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Cellesce Ltd
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Hubrecht Organoid Technology
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Definigen
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Thermo Fisher Scientific Inc
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Merck KGaA
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.7 InSphero
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments

15. Appendix

  • 15.1 About Us
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Organoids Market Segmentation
  • Table 2. Germany Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 3. Germany Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 4. Germany Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 5. Germany Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 6. UK Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 7. UK Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 8. UK Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 9. UK Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 10. France Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 11. France Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 12. France Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 13. UK Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 14. Italy Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 15. Italy Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 16. Italy Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 17. Italy Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 18. Spain Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 19. Spain Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 20. Spain Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 21. Spain Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 22. Rest of Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 23. Rest of Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 24. Rest of Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 25. Rest of Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 26. Organic Developments Done by Companies
  • Table 27. Inorganic Developments Done by Companies
  • Table 28. Glossary of Terms, Europe Organoids Market

List Of Figures

  • Figure 1. Europe Organoids Market Segmentation, By Country
  • Figure 2. Europe - PEST Analysis
  • Figure 3. Europe Organoids Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Europe Organoids Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Europe Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
  • Figure 7. Stomach: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Intestine: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Liver: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Pancreas: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Lung: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Brain: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Kidney: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Europe Organoids Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 16. Developmental Biology: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Disease Pathology of Infectious Disease: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Regenerative Medicine: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Drug Toxicity and Efficacy Testing: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Drug Discovery and Personalized Medicine: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Others: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Europe Organoids Market Revenue Share, by Source 2022 & 2030 (%)
  • Figure 23. Pluripotent Stem Cells: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Organ-specific Adult Stem Cells: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Europe Organoids Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 26. Instruments: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Consumables: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Services: Europe Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Europe Organoids Market, By Country - Revenue (2022) ($Mn)
  • Figure 30. Europe Organoids Market, By Key Countries, 2022 And 2030 (%)
  • Figure 31. Germany Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 32. UK Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 33. France Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Italy Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 35. Spain Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. Rest of Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 37. Pre & Post COVID-19 Impact
  • Figure 38. Growth Strategies Done by the Companies in the Market, (%)